Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study

Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study

Abstract Background Major depressive disorder (MDD) is a common psychiatric disorder. With systematic antidepressant treatment, 50–75% of patients have a treatment response but require 4–6 weeks to have their symptoms alleviated. Therefore, researchers anticipate the development of novel fast-acting...

Full description

Bibliographic Details
Main Authors: Yiyi Chen, Xiaomin Cao, Wensi Zang, Shanyong Tan, Chun-quan Ou, Xiaoyan Shen, Tianming Gao, Lianxu Zhao
Format: Article
Language:English
Published: BMC 2019-01-01
Series:Trials
Subjects:
Major depressive disorder
Adenosine triphosphate
Phosphocreatine
Fluoxetine
Fast-acting antidepressant
Randomized controlled trial
Online Access:http://link.springer.com/article/10.1186/s13063-018-3115-4

Internet

http://link.springer.com/article/10.1186/s13063-018-3115-4

Similar Items